• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB ADAPTIVE FLUIDICS MICS PREMIUM PACKS; UNIT PHACOFRAGMENTATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB ADAPTIVE FLUIDICS MICS PREMIUM PACKS; UNIT PHACOFRAGMENTATION Back to Search Results
Model Number BL5115-3
Device Problem Material Fragmentation (1261)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/17/2021
Event Type  malfunction  
Event Description
The user facility in the netherlands reported during the sculpt portions of cataract surgery some blue/white fibers appeared in the anterior chamber, as well as a metal particle.
 
Manufacturer Narrative
Though requested the particulate sample has not been returned for evaluation at this time.A lot number was not provided; therefore, the sterilization and lot history records could not be reviewed.
 
Manufacturer Narrative
The trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates.
 
Manufacturer Narrative
The particles were microscopically examined, and measured using a camera equipped optical stereo microscope.One particle exhibited a fragile, blue appearance while the other exhibited a metallic appearance.The particles were also analyzed using an energy dispersive spectrometer (eds) equipped with a scanning electron microscope (sem).Eds analysis of the blue particle indicated that it consisted primarily of carbon, chlorine, and sodium.Lesser concentrations of oxygen, silicon, phosphorus, and magnesium were also detected.This is consistent with salt and organic material.Eds analysis of the metallic particle indicated that it consists primarily of titanium.Lesser concentrations of aluminum and vanadium were also detected.This is consistent with titanium alloy.We are unable to definitively identify the source of the particles.
 
Manufacturer Narrative
A visual inspection was completed.One opened bl5115-3 combined dpi tube with stable chamber tray was returned.Visual inspection found the tubing was tangled and loosely packed with an empty bss bottle.No other content was returned.The lot number and expiration date is unknown.Under microscopic visual inspection found a bluish feathery type material, along with a darker particle that appeared to be a harder substance.The particulate will be sent to a testing lab for further results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADAPTIVE FLUIDICS MICS PREMIUM PACKS
Type of Device
UNIT PHACOFRAGMENTATION
Manufacturer (Section D)
BAUSCH + LOMB
rochester NY 14609
Manufacturer (Section G)
BAUSCH + LOMB, INC.
3365 tree court industrial blv
st. louis MO 63122
Manufacturer Contact
juli moore
3365 tree court industrial blv
st. louis, MO 63122
MDR Report Key12984347
MDR Text Key283409421
Report Number0001920664-2021-00158
Device Sequence Number1
Product Code HQC
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
K170052
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 11/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model NumberBL5115-3
Device Catalogue NumberBL5115-3
Device Lot Number222
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/27/2022
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/18/2021
Initial Date FDA Received12/13/2021
Supplement Dates Manufacturer Received01/03/2022
01/31/2022
02/24/2022
Supplement Dates FDA Received01/25/2022
02/22/2022
03/20/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
STELLARIS UNIT.
-
-